<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: AstraZeneca shares begin rally as Oxford vaccine trial resumes	</title>
	<atom:link href="https://ukinvestormagazine.co.uk/astrazeneca-shares-begin-rally-as-oxford-vaccine-trial-resumes/feed/" rel="self" type="application/rss+xml" />
	<link>https://ukinvestormagazine.co.uk/astrazeneca-shares-begin-rally-as-oxford-vaccine-trial-resumes/</link>
	<description>UK Investor Magazine provides breaking financial news and investment ideas</description>
	<lastBuildDate>Tue, 13 Oct 2020 14:25:49 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0.2</generator>
	<item>
		<title>
		By: Johnson &#38; Johnson shares slide as vaccine trial put on hold - UK Investor Magazine		</title>
		<link>https://ukinvestormagazine.co.uk/astrazeneca-shares-begin-rally-as-oxford-vaccine-trial-resumes/#comment-16083</link>

		<dc:creator><![CDATA[Johnson &#38; Johnson shares slide as vaccine trial put on hold - UK Investor Magazine]]></dc:creator>
		<pubDate>Tue, 13 Oct 2020 14:25:49 +0000</pubDate>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=30969#comment-16083</guid>

					<description><![CDATA[[&#8230;] Regulators later deemed the trial safe to go ahead, but not without dealing a heavy blow to hopes that the development of an effective coronavirus vaccine will be a smooth and swift ride. [&#8230;]]]></description>
			<content:encoded><![CDATA[<p>[&#8230;] Regulators later deemed the trial safe to go ahead, but not without dealing a heavy blow to hopes that the development of an effective coronavirus vaccine will be a smooth and swift ride. [&#8230;]</p>
]]></content:encoded>
		
			</item>
		<item>
		<title>
		By: AstraZeneca and GlaxoSmithKline - the Covid-19 vaccine frontrunners to watch - UK Investor Magazine		</title>
		<link>https://ukinvestormagazine.co.uk/astrazeneca-shares-begin-rally-as-oxford-vaccine-trial-resumes/#comment-15954</link>

		<dc:creator><![CDATA[AstraZeneca and GlaxoSmithKline - the Covid-19 vaccine frontrunners to watch - UK Investor Magazine]]></dc:creator>
		<pubDate>Wed, 23 Sep 2020 14:10:49 +0000</pubDate>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=30969#comment-15954</guid>

					<description><![CDATA[[&#8230;] biopharmaceutical firms have emerged among the frontrunners in the race to develop a vaccine: AstraZeneca (LON:AZN) and GlaxoSmithKline [&#8230;]]]></description>
			<content:encoded><![CDATA[<p>[&#8230;] biopharmaceutical firms have emerged among the frontrunners in the race to develop a vaccine: AstraZeneca (LON:AZN) and GlaxoSmithKline [&#8230;]</p>
]]></content:encoded>
		
			</item>
	</channel>
</rss>
